Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
InventisBio
company
About
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
- 1 - 10
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $147M
- Industries
- Biopharma,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$247M
InventisBio has raised a total of
$247M
in funding over 2 rounds. Their latest funding was raised on
Sep 27, 2020 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 27, 2020 | Series D | $147M | 2 | — | — | Detail |
| Mar 12, 2019 | Series C | $70M | 1 | — | — | Detail |
| May 30, 2017 | Series B | $19M | 1 | — | — | Detail |
| Jan 1, 2016 | Series A | $11M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
InventisBio is funded by 2 investors.
Pudong Innotek
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
Lilly Asia Ventures
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
